NCT00001035View on ClinicalTrials.gov

The Safety and Effectiveness of a Two-Drug Combination in the Treatment of Patients With Hepatitis C Plus Advanced HIV Infections

PHASE1CompletedINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

Not specified

Study Completion Date

September 30, 1996

Conditions

HIV InfectionsHepatitis C

Interventions

DRUG

Interferon alfa-2b

DRUG

Zidovudine

DRUG

Zalcitabine

DRUG

Didanosine

Trial Locations (3)

10016

NY Univ. HIV/AIDS CRS, New York

462025250

Indiana Univ. School of Medicine, Infectious Disease Research Clinic, Indianapolis

Unknown

USC CRS, Los Angeles

Sponsors

Collaborators (1)

Schering-Plough

All Listed Sponsors

collaborator

Schering-Plough

INDUSTRY

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH